Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value

BACKGROUND: Demonstrating safety and efficacy of new medical treatments requires clinical trials but clinical trials are costly and may not provide value proportionate to their costs. As most health systems have limited resources, it is therefore important to identify the trials with the highest val...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillett, Piers, Mahar, Robert K, Tran, Nancy R, Rosenthal, Mark, IJzerman, Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647033/
https://www.ncbi.nlm.nih.gov/pubmed/37964269
http://dx.doi.org/10.1186/s12962-023-00496-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647033/
https://www.ncbi.nlm.nih.gov/pubmed/37964269
http://dx.doi.org/10.1186/s12962-023-00496-y

Ejemplares similares